Overview
Andrew Himelstein is a Hematologist Oncology specialist and a Palliative Medicine provider in Newark, Delaware. Dr. Himelstein is rated as an Advanced provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Inflammatory Breast Cancer, Paget Disease of the Breast, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Familial Prostate Cancer. Dr. Himelstein is currently accepting new patients.
His clinical research consists of co-authoring 5 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- PPO
- EPO
- HMO
- PPO
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
4701 Ogletown Stanton Rd, Suite 3400, Newark, DE 19713
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Kristopher Bosse is a Pediatrics specialist and a Hematologist in Philadelphia, Pennsylvania. Dr. Bosse is rated as a Distinguished provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Neuroblastoma, Embryonal Tumor with Multilayered Rosettes, Gliomatosis Cerebri, and Adrenal Cancer.
Skip Viragh Outpatient Cancer Center
Dr. Matthias Holdhoff is a medical oncologist and co-director of the Brain Cancer Disease Group at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. He is a professor of oncology, neurology and neurological surgery at Johns Hopkins University School of Medicine. Dr. Holdhoff’s expertise is in primary brain cancers and central nervous system lymphomas. He earned his medical degree from Freie Universität Berlin, received his doctorate degree at Charité University Medicine Berlin. Dr. Holdhoff completed residency training in internal medicine at Johns Hopkins Bayview Medical Center, followed by a fellowship in medical oncology at Johns Hopkins Hospital with research training at the Ludwig Center for Cancer Genetics and Therapeutics (Kinzler-Vogelstein lab). As a clinical investigator in neuro-oncology, his research is focused on novel trials and translational biomarker studies in malignant gliomas and primary central nervous system lymphomas. He has led and contributed to numerous clinical trials, publications and presentations. Dr. Holdhoff serves as the director of the solid tumor inpatient service at the Sidney Kimmel Comprehensive Cancer Center. He is passionately involved in mentoring and teaching of fellows, residents and students. He is the director of the UCNS-certified neuro-oncology fellowship program at Johns Hopkins, and he is a teaching attending physician for the Osler internal medicine residency program. Dr. Holdhoff is rated as an Elite provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. His top areas of expertise are Glioma, Glioblastoma, Astrocytoma, and Brain Tumor.
Abramson Cancer Center Perelman 2nd Floor West
Arati Desai is an Oncologist in Philadelphia, Pennsylvania. Dr. Desai is rated as an Elite provider by MediFind in the treatment of Embryonal Tumor with Multilayered Rosettes. Her top areas of expertise are Glioblastoma, Astrocytoma, Glioma, and Gliomatosis Cerebri. Dr. Desai is currently accepting new patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Familial Prostate CancerDr. Himelstein isDistinguished. Learn about Familial Prostate Cancer.
- Inflammatory Breast CancerDr. Himelstein isDistinguished. Learn about Inflammatory Breast Cancer.
- Lung CancerDr. Himelstein isDistinguished. Learn about Lung Cancer.
- Monoclonal Gammopathy of Undetermined Significance (MGUS)
- Paget Disease of the BreastDr. Himelstein isDistinguished. Learn about Paget Disease of the Breast.
- Pleuropulmonary BlastomaDr. Himelstein isDistinguished. Learn about Pleuropulmonary Blastoma.
- Advanced
- Acquired HemophiliaDr. Himelstein isAdvanced. Learn about Acquired Hemophilia.
- Acute Mountain SicknessDr. Himelstein isAdvanced. Learn about Acute Mountain Sickness.
- Adult Immune ThrombocytopeniaDr. Himelstein isAdvanced. Learn about Adult Immune Thrombocytopenia.
- AngiosarcomaDr. Himelstein isAdvanced. Learn about Angiosarcoma.
- Appendix CancerDr. Himelstein isAdvanced. Learn about Appendix Cancer.
- AstrocytomaDr. Himelstein isAdvanced. Learn about Astrocytoma.
- Experienced
- Acute Eosinophilic PneumoniaDr. Himelstein isExperienced. Learn about Acute Eosinophilic Pneumonia.
- Acute Hepatic Porphyria (AHP)Dr. Himelstein isExperienced. Learn about Acute Hepatic Porphyria (AHP).
- Acute Intermittent PorphyriaDr. Himelstein isExperienced. Learn about Acute Intermittent Porphyria.
- Adult Soft Tissue SarcomaDr. Himelstein isExperienced. Learn about Adult Soft Tissue Sarcoma.
- AgranulocytosisDr. Himelstein isExperienced. Learn about Agranulocytosis.
- ALK-Positive Non-Small Cell Lung CancerDr. Himelstein isExperienced. Learn about ALK-Positive Non-Small Cell Lung Cancer.
